Biotickr logobiotickr

Company Description

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. We founded atai in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics.


Introspect believes that high-quality digital combination therapies will increase the safety and effectiveness of many mental health drugs. Digital therapeutics (DTx) will provide personalized and scalable treatment to those who might not otherwise be able to access high-quality psychological care.

Psilocybin, ibogaine, and many other psychedelic substances have yielded remarkable early signals of their efficacy in treating everything from depression to various forms of addiction. And while Dr. Srinivas Rao, Chief Executive Officer of EntheogeniX Biosciences, shares the cautious optimism of many researchers, he’s careful to point out that these and other substances come with two significant obstacles…

InnarisBio specialized in drug formulation bringing its sol-gel based, intranasal excipient technology to atai. The novel technology may enable new drug formulations with unique and optimized modes of delivery across various active ingredients in the atai pipeline, as well as potential assets in the future.

PsyProtix is taking a precision psychiatry approach to develop metabolomics-based biomarkers to stratify patients with treatment-resistant depression (TRD) and other mental health indications. By identifying patient subsets with unique metabolic profiles, PsyProtix will test mechanism-based treatments with the goal of improving overall outcomes.

Drug Pipeline

Source: ATAI Life Sciences N.V. - 20221113
Anorexia Nervosa
Phase 2
Phase 2
Post-Traumatic Stress Disorder
Phase 2
Opioid Use Disorder
Phase 1
Post-Traumatic Stress Disorder
Anxiety Disorder
Phase 1
Opioid Use Disorder
Phase 1


0 following
Messages Image
Log in or sign up to join the conversation.

0 Comments on 9VC-GF stock